Profiles

Keywords
Last Name
Institution

Connection

Annabelle Volgman to Male

This is a "connection" page, showing publications Annabelle Volgman has written about Male.

 
Connection Strength
 
 
 
1.040
 
  1. Khandelwal A, Bakir M, Bezaire M, Costello B, Gomez JMD, Hoover V, Nazir NT, Nichols K, Reisenberg A, Rao A, Sanghani R, Tracy M, Volgman AS. Managing Ischemic Heart Disease in Women: Role of a Women's Heart Center. Curr Atheroscler Rep. 2021 08 04; 23(10):56.
    View in: PubMed
    Score: 0.063
  2. Abugroun A, Elawad A, Okoh AK, Abdel-Rahman ME, Ayinde H, Volgman AS. Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients = 60 Years with Implantable Cardioverter Defibrillator. Am J Cardiol. 2021 08 01; 152:94-98.
    View in: PubMed
    Score: 0.062
  3. Gomez JMD, Du-Fay-de-Lavallaz JM, Fugar S, Sarau A, Simmons JA, Clark B, Sanghani RM, Aggarwal NT, Williams KA, Doukky R, Volgman AS. Sex Differences in COVID-19 Hospitalization and Mortality. J Womens Health (Larchmt). 2021 05; 30(5):646-653.
    View in: PubMed
    Score: 0.062
  4. Volgman AS, Benjamin EJ, Curtis AB, Fang MC, Lindley KJ, Naccarelli GV, Pepine CJ, Quesada O, Vaseghi M, Waldo AL, Wenger NK, Russo AM. Women and atrial fibrillation. J Cardiovasc Electrophysiol. 2021 10; 32(10):2793-2807.
    View in: PubMed
    Score: 0.060
  5. Abugroun A, Taha A, Abdel-Rahman M, Volgman AS. Economic Impact of Atrial Fibrillation on Hospitalization Outcomes of Acute Heart Failure in the United States. Am J Cardiol. 2021 01 01; 138:124-127.
    View in: PubMed
    Score: 0.060
  6. Madan N, Gajo E, Sanghani RM, Volgman AS. Sex-Based Considerations in the Evaluation of Chest Pain and Management of Obstructive Coronary Artery Disease. Curr Atheroscler Rep. 2020 06 23; 22(8):39.
    View in: PubMed
    Score: 0.058
  7. Volgman AS, Bairey Merz CN, Aggarwal NT, Bittner V, Bunch TJ, Gorelick PB, Maki P, Patel HN, Poppas A, Ruskin J, Russo AM, Waldstein SR, Wenger NK, Yaffe K, Pepine CJ. Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women? J Am Heart Assoc. 2019 10; 8(19):e013154.
    View in: PubMed
    Score: 0.055
  8. Agdamag AC, Patel H, Chandra S, Rao A, Suboc TM, Marinescu K, Ledsky C, Volgman AS. Sex Differences in Takotsubo Syndrome: A Narrative Review. J Womens Health (Larchmt). 2020 08; 29(8):1122-1130.
    View in: PubMed
    Score: 0.055
  9. Halloway S, Wilbur J, Schoeny ME, Braun LT, Aggarwal NT, Miller AM, Crane MM, Volgman AS. Feasibility of a Lifestyle Physical Activity Intervention to Prevent Memory Loss in Older Women With Cardiovascular Disease: A Mixed-Methods Approach. Can J Nurs Res. 2020 Dec; 52(4):278-289.
    View in: PubMed
    Score: 0.055
  10. Madan N, Itchhaporia D, Albert CM, Aggarwal NT, Volgman AS. Atrial Fibrillation and Heart Failure in Women. Heart Fail Clin. 2019 Jan; 15(1):55-64.
    View in: PubMed
    Score: 0.052
  11. Volgman AS, Dembowski E, Braun LT. Should Sex Matter When it Comes to High-Intensity Statins? J Am Coll Cardiol. 2018 04 24; 71(16):1738-1740.
    View in: PubMed
    Score: 0.050
  12. Mehta DD, Nazir NT, Trohman RG, Volgman AS. Single-lead portable ECG devices: Perceptions and clinical accuracy compared to conventional cardiac monitoring. J Electrocardiol. 2015 Jul-Aug; 48(4):710-6.
    View in: PubMed
    Score: 0.041
  13. Attaya S, Bornstein T, Ronquillo N, Volgman R, Braun LT, Trohman R, Volgman A. Study of warfarin patients investigating attitudes toward therapy change (SWITCH Survey). Am J Ther. 2012 Nov; 19(6):432-5.
    View in: PubMed
    Score: 0.034
  14. Enriquez JR, Pratap P, Zbilut JP, Calvin JE, Volgman AS. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med. 2008 Mar; 5(1):53-61.
    View in: PubMed
    Score: 0.025
  15. Moledina SM, Rashid M, Nolan J, Nakao K, Sun LY, Velagapudi P, Wilton SB, Volgman AS, Gale CP, Mamas MA. Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study. Eur J Prev Cardiol. 2022 05 25; 29(7):1084-1092.
    View in: PubMed
    Score: 0.017
  16. Ruge M, Gomez JMD, du Fay de Lavallaz J, Hlepas A, Rahman A, Patel P, Lavani P, Nair GG, Jahan N, Simmons JA, Rao AK, Williams KA, Volgman AS, Marinescu K, Suboc T. The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol. 2021 Nov-Dec; 55:107374.
    View in: PubMed
    Score: 0.016
  17. Van Spall HGC, Lala A, Deering TF, Casadei B, Zannad F, Kaul P, Mehran R, Pearson GD, Shah MR, Gulati M, Grines C, Volgman AS, Revkin JH, PiƱa I, Lam CSP, Hochman JS, Simon T, Walsh MN, Bozkurt B. Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 06 15; 77(23):2960-2972.
    View in: PubMed
    Score: 0.016
  18. Okwuosa TM, Morgans A, Rhee JW, Reding KW, Maliski S, Plana JC, Volgman AS, Moseley KF, Porter CB, Ismail-Khan R. Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2021 06; 14(3):e000082.
    View in: PubMed
    Score: 0.015
  19. Wang SC, Koutroumpakis E, Schulman-Marcus J, Tosh T, Volgman AS, Lyubarova R. Sex Differences Remain Under-Reported in Cardiovascular Publications. J Womens Health (Larchmt). 2021 09; 30(9):1253-1258.
    View in: PubMed
    Score: 0.015
  20. Halloway S, Schoeny ME, Barnes LL, Arvanitakis Z, Pressler SJ, Braun LT, Volgman AS, Gamboa C, Wilbur J. A study protocol for MindMoves: A lifestyle physical activity and cognitive training intervention to prevent cognitive impairment in older women with cardiovascular disease. Contemp Clin Trials. 2021 02; 101:106254.
    View in: PubMed
    Score: 0.015
  21. Hassan A, Abugroun A, Daoud H, Mahmoud S, Awadalla S, Volgman A, Alonso A. Impact of Gender Differences on Outcomes of Peripheral Artery Disease Intervention (from a Nationwide Sample). Am J Cardiol. 2021 02 15; 141:127-132.
    View in: PubMed
    Score: 0.015
  22. Okunrintemi V, Tibuakuu M, Virani SS, Sperling LS, Volgman AS, Gulati M, Cho L, Leucker TM, Blumenthal RS, Michos ED. Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey. J Am Heart Assoc. 2020 12 15; 9(24):e018764.
    View in: PubMed
    Score: 0.015
  23. Kolkailah AA, Doukky R, Pelletier MP, Volgman AS, Kaneko T, Nabhan AF. Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Heart. 2020 07; 106(14):1043-1045.
    View in: PubMed
    Score: 0.015
  24. Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK, Michos ED, Minissian M, Pepine C, Vaccarino V, Volgman AS. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 05 26; 75(20):2602-2618.
    View in: PubMed
    Score: 0.015
  25. Matetic A, Bharadwaj A, Mohamed MO, Chugh Y, Chugh S, Minissian M, Amin A, Van Spall H, Fischman DL, Savage M, Volgman AS, Mamas MA. Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction. Am J Cardiol. 2020 08 15; 129:10-18.
    View in: PubMed
    Score: 0.015
  26. Mohamed MO, Greenspon A, Van Spall H, Volgman AS, Sharma PS, Alraies MC, Kwok CS, Martin GP, Zachariah D, Patwala A, Mamas MA. Sex differences in rates and causes of 30-day readmissions after cardiac electronic device implantations: insights from the Nationwide Readmissions Database. Int J Cardiol. 2020 03 01; 302:67-74.
    View in: PubMed
    Score: 0.014
  27. Martin GP, Kwok CS, Van Spall HGC, Volgman AS, Michos E, Parwani P, Alraies C, Thamman R, Kontopantelis E, Mamas M. Readmission and processes of care across weekend and weekday hospitalisation for acute myocardial infarction, heart failure or stroke: an observational study of the National Readmission Database. BMJ Open. 2019 08 22; 9(8):e029667.
    View in: PubMed
    Score: 0.014
  28. Mohamed MO, Volgman AS, Contractor T, Sharma PS, Kwok CS, Rashid M, Martin GP, Barker D, Patwala A, Mamas MA. Trends of Sex Differences in Outcomes of Cardiac Electronic Device Implantations in the United States. Can J Cardiol. 2020 01; 36(1):69-78.
    View in: PubMed
    Score: 0.014
  29. Mohamed MO, Sharma PS, Volgman AS, Bhardwaj R, Kwok CS, Rashid M, Barker D, Patwala A, Mamas MA. Prevalence, Outcomes, and Costs According to Patient Frailty Status for 2.9 Million Cardiac Electronic Device Implantations in the United States. Can J Cardiol. 2019 11; 35(11):1465-1474.
    View in: PubMed
    Score: 0.014
  30. Kwok CS, Walsh MN, Volgman A, Alasnag M, Martin GP, Barker D, Patwala A, Bagur R, Fischman DL, Mamas MA. Discharge against medical advice after hospitalisation for acute myocardial infarction. Heart. 2019 02; 105(4):315-321.
    View in: PubMed
    Score: 0.013
  31. Volgman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, Vanderlugt JT, Kowey PR. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol. 1998 May; 31(6):1414-9.
    View in: PubMed
    Score: 0.013
  32. Aggarwal NR, Patel HN, Mehta LS, Sanghani RM, Lundberg GP, Lewis SJ, Mendelson MA, Wood MJ, Volgman AS, Mieres JH. Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps. Circ Cardiovasc Qual Outcomes. 2018 02; 11(2):e004437.
    View in: PubMed
    Score: 0.012
  33. Volgman AS, Soble JS, Neumann A, Mukhtar KN, Iftikhar F, Vallesteros A, Liebson PR. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging. 1996 Oct; 10(4):261-5.
    View in: PubMed
    Score: 0.011
  34. Volgman AS, Zheutlin TA, Mattioni TA, Parker MA, Kehoe RF. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease. Am J Cardiol. 1992 Sep 15; 70(7):758-63.
    View in: PubMed
    Score: 0.009
  35. Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, Frison L, Halperin JL. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J. 2006 Aug; 27(16):1947-53.
    View in: PubMed
    Score: 0.006
  36. Raitt MH, Volgman AS, Zoble RG, Charbonneau L, Padder FA, O'Hara GE, Kerr D. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2006 Feb; 151(2):390-6.
    View in: PubMed
    Score: 0.005
  37. Wyse DG, Slee A, Epstein AE, Gersh BJ, Rocco T, Vidaillet H, Volgman A, Weiss R, Shemanski L, Greene HL. Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience. Heart Rhythm. 2004 Nov; 1(5):531-7.
    View in: PubMed
    Score: 0.005
  38. Silvestri JM, Hanna BD, Volgman AS, Jones PJ, Barnes SD, Weese-Mayer DE. Cardiac rhythm disturbances among children with idiopathic congenital central hypoventilation syndrome. Pediatr Pulmonol. 2000 May; 29(5):351-8.
    View in: PubMed
    Score: 0.004
  39. Buckingham TA, Radin MM, Volgman AS, Jhangiani A, Zbilut J. Does atrial fibrillation cause false-positive late potentials? Pacing Clin Electrophysiol. 1993 Dec; 16(12):2222-6.
    View in: PubMed
    Score: 0.002
  40. Susmano A, Volgman AS, Buckingham TA. Beneficial effects of dextro-amphetamine in the treatment of vasodepressor syncope. Pacing Clin Electrophysiol. 1993 Jun; 16(6):1235-9.
    View in: PubMed
    Score: 0.002
  41. Buckingham TA, Greenwalt T, Lingle A, Volgman AS, Kober P, Janosik D, Zbilut JP. In anterior myocardial infarction, frequency domain is better than time domain analysis of the signal-averaged ECG for identifying patients at risk for sustained ventricular tachycardia. Pacing Clin Electrophysiol. 1992 Nov; 15(11 Pt 1):1681-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.